chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient recieved vaccine at 10 AM at a school COVID clinic. She waited 30 minutes and went home. At around 11 AM, she felt pain in her neck and down her arm. She also stated she felt a little swollen in her throat, tongue, eyes, and ears. She said it was not swelling shut, but just an uncomfortable and never felt in danger. Her hands and chest also had a tightness and swelling to them.  Later that night she had a headache behind her eyes. By Saturday she was fine with the "swollen" feeling. However, by Monday, she had a rash begin on her hands and stomach. The rash was described as a chicken pox rash. She said this just went away over the last couple of days and did leave very little scarring.
Info has been received from an RN concerning a 12 month old white female child with no pre-existing allergies, birth defects or medical conditions, who on 3/21/06 at 10:00 AM, was vaccinated, SC, in the left thigh, with a 1st dose of MMRII (lot 651813/0770R). Concomitant vaccinations included the 3rd dose of Hib conj.-hepatitis B vaccine (lot 651838/0359R) given IM, in the right thigh and the 1st dose of Hep-A vaccine (lot 652085/1069R), given IM, in the right thigh. There was no illness at the time of vaccination. On 3/30/06, the pt developed a fever 102.6F and a rash on face and stomach. The rash spread to her entire body including her torso, arms and legs. The pt was seen in the ER. It was reported that they appeared like red mosquito-like bites with positive blanching. The pt was happy and pleasant and did not appear itchy. At the time of this report, the pt still had a rash and was not completely recovered. Additional info has been received from an RN on 5/31/06, indicating that the pt's rash completely cleared and she was free of signs and symptoms and recovered as of 4/5/06. No further info is expected.
About 3 hrs after my vaccine, I first felt like I had a hot flash, then a few minutes later I got extremely dizzy I couldn't even hold my head up, I was visibly shaking like tremors,  I was pale, had a low grade fever,  was nauseas and vomitted one time. All of this lasted only one to 2 hours except for the nausea, which lasted 2 days however after the initial 2 hour period it was not that bad, just a little queasy  feeling. The onset really felt like my blood sugar bottomed out.
This infant's mother stated that on 08/15/01 at 4 PM this child had a severe asthmatic reaction, turned blue, retractions and rales. Taken to the ER 9 PM at the hospital until Wednesday afternoon.
This spontaneous report was received from a medical assistant and refers to a 14-year-old patient of unknown gender. The patient's pertinent medical history, concomitant therapies, drug reactions or allergies were not reported. On an unknown date in 2016, the patient was vaccinated with the first dose of their human papilloma virus (HPV) vaccination series with GARDASIL 9 intramuscularly (dose, lot # and expiration date were not provided) for prophylaxis. On an unknown date in 2018, the patient was vaccinated with the second dose of their HPV vaccination series with GARDASIL 9 intramuscularly (dose, lot # and expiration date were not provided) for prophylaxis. No adverse effects were reported.
cardiac arrhythmia; Atrial fibrillation; This is a spontaneous report from a contactable consumer. An 83-year-old male patient received the first dose of bnt162b2 (BNT162B2, Batch/Lot Number: EL8932), via an unspecified route of administration, administered in the left arm on 21Jan2021 as a single dose for covid-19 immunization. The patient's medical history included type 2 diabetes mellitus from an unknown date and unknown if ongoing , Defibrillator/pacemaker insertion from 2015 to an unknown date. Concomitant medication included insulin (INSULIN) taken for an unspecified indication, start and stop date were not reported. The next day after 1st dose the patient experienced a 7hr period of atrial fibrillation (all recorded on a cardiac monitor), he stated he was dizzy, light headedness and periods of shortness of breath. He just became aware of this cardiac arrhythmia from his Cardiologist. He has an internal heart monitor and the Doctor was able to see this report. He was now taking medication for A-FIB. It was reported that patient never had it until the night he got the shot. The outcome of the events was unknown.
8-10 hours post-dose: 1. Headache - treated with OTC meds, lasting  27 hours 2. Fever - 99.5 - 100F, treated with OTC meds, lasting 27 hours 3. Muscle aches/fatigue- treated with OTC meds, rest, lasting 30 hours 4. Lymphadenopathy- left armpit, same side as injection.  Not resolved at  42 hours 5. Injection site swelling/pain - treated with OTC meds, not resolved at 42 hours
On 1/17/2023 symptoms started, runny nose, congestion, sore throat
Swelling of left arm from shoulder to elbow, tender to touch and filled with fluid (edema).
Body ache; low grade fever; This follow-up case was missing the following minimum criteria: no adverse effect. Upon receipt of follow-up information on 26Dec2020, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable other hcp (patient). A 36-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: J1685), via an unspecified route of administration in the left arm on 22Dec2020 13:15 at a single dose for COVID-19 immunization at the hospital. The patient has no medical history. The patient was not diagnosed with COVID-19 prior vaccination and has not been tested for COVID-19 post vaccination. The patient has no known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Dec2020, the patient had body ache and low grade fever that began 2 - 3 days after vaccination. Outcome of the events was not recovered. The events were assessed as non-serious.
Vaccine was not completely thawed before administration; A spontaneous report was received from a pharmacist concerning a patient who received Moderna's Covid-19 vaccine (mRNA-1273) and vaccine was not completely thawed.  The patient's medical history was not provided. Concomitant product use was not provided.  The patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) on (date not provided) intramuscularly for prophylaxis of COVID-19 infection.   The reporter stated that the patient received a dose of the Moderna COVID-19 vaccine 30 minutes after being taken out of the freezer instead of the full hour. The vaccinator was able to draw up a full dose (liquid) and administer the vaccine, however the vaccine was not completely thawed.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not provided.   The events, vaccine was not completely thawed, was considered resolved.; Reporter's Comments: This report refers to product preparation error, where the patient was administered mRNA-1273 that was not completely thawed. There were no reported AEs associated with this case of product preparation error.
Large, painful cervical adenopathy and painful swallowing limited to L side, onset 1 d after receipt, severe X 5 d, cervical adenopathy persistent at d 10
Patient given Pfizer for first covid vaccine dose. Mistakenly given Moderna for second dose.  Infectious Disease specialist consulted.
8 days after initial shot I'm experiencing what started as an itch. The area of injection swelled and is red again. The itchiness is pretty bad and now on day 9 I'm feeling heat and some pain in injection site. I googled symptoms and I think I'm experiencing Covid arm. Oral benedryl and icing the area seems to be helping.
Pain & swelling of 3rd digit of rt hand w/some inflammation & tenderness on 15AUG91; Generalized adenopathy;
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 11-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No treatment medications were reported.      This case was linked to MOD-2021-364549 (Patient Link).
Child was given a booster dose of Pfizer without meeting the age requirement of 16 years.
Initial report received from a pharmacist on 03 Mar 2011: This patient was vaccinated with FLUVIRIN (batch number 1118076P1) (dose unspecified) intramuscularly on an unknown date. The patient had cellulitis in right arm after receiving vaccine from an unknown date. The patient received a prescription for an antibiotic treatment in the same arm. The outcome of the event was reported as ongoing. The causality of the event was not reported. Follow up report received from the pharmacist on 04 Apr 2011: The patient was vaccinated with FLUVIRIN 0.5 ml dose at left deltoid on 25 Feb 2011. On the same day, the patient was also vaccinated with PNEUMOVAX (batch no: 06512), 0.5 ml, intramuscularly, on left deltoid. The patient experienced redness and swelling in left arm from elbow to shoulder on 26 Feb 2011. The patient recovered from these events on 08 Mar 2011. The reporter assessed the events as serious (medically significant) but no causality assessment was provided.
Dizziness when getting up from laying down, or when looking up. Also teeth sensitivity only on top right side of the mouth just started today - 5 days after the first injection.
Telephone consult performed on 05/27/2021 @ 1530 by APRN.  Pt assessed by Nurse at vaccination site.   Pt received Moderna COVID-19 vaccine dose #1 on 05/27/2021 at 1415.  Pt was observed for 15 minutes at vaccination site, left at 1430 without reactions.  Nurse documented on vaccine consent form:   1530- Pt returned to vaccination location complaining of sudden onset of blurred vision and ocular pressure to right eye.  Denies H/A, N/V, dizziness. Bilateral equal hand grasp. Denies history of migraines. BP 160/80; P 84; R 18; O2 sat 98% on room air.    1539: APRN called for consult and spoke to the patient.  Pt reports a partial loss of vision to right eye which has subsided, but persistent bilateral blurred vision remains.  Pt sts visual changes began ~ 1515.  Pt reports he has a childhood stutter.  Pt denies H/A, changes in speech, hearing, memory.  Denies LOC/falls or dysequilibrium.  Denies any medical history, including HTN.  Pt is alert, oriented x 4.    Discussed possibility of CVA with the patient and the need for emergent care via EMS, and explained rationale.  Pt understood and agrees.  notified 911. 1607:  EMS arrival.  Medics verbally report BP 158/100 on first set of VS to Nurse.  Pt left vaccination site via EMS to be transported to Hospital.
I had nausea; I had arm pain; headaches; extreme fatigued; develop a red rash on my hands and arms / Two weeks later the rash covered both my arms /Two weeks later the rash covered both my arms / the rash was now on my back, my neck and starting on my legs; This case was reported by a consumer via call center representative and described the occurrence of nausea in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th December 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced nausea, pain in arm, headache, fatigue and red rash. The patient was treated with prednisone and steroid cream. On an unknown date, the outcome of the nausea, pain in arm, headache and fatigue were recovered/resolved and the outcome of the red rash was not recovered/not resolved.   It was unknown if the reporter considered the nausea, pain in arm, headache, fatigue and red rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had nausea, arm pain, headaches, and extreme fatigue after vaccination. The patient started to develop a red rash on hands and arms and later the rash covered both arms and within another week the rash was now on back, neck and starting on legs. The patient question was how long would this rash last and Would I always have this rash.      Lab Comments: done on an unknown date
left hip hurt then her right hip would start hurting; body aches/It would ache in one spot then another spot; hurt more at the shot site with the first Covid 19 vaccine/pain that day afterwards; on the whole left side where she had the first shot; This is a spontaneous report from a contactable consumer (patient) or other non HCP.   A 89-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6201, Expiration date not reported), via an unspecified route of administration, administered in left arm on an unknown date in Feb2021 as dose 1, single (at the age of 89-years-old) for covid-19 immunization. The patient's medical history included ongoing ankylosis spondylosis (when she was real young, a kid, first time it was noticed was when she was a child, exercising in PE she could not touch her toes, states it's autoimmune), ongoing GERD (gastrooesophageal reflux disease) 30-40 years, ongoing hiatus hernia 30-40 years, gradually gotten worse, has a lot of pain and restrictions with food intake, she should have had an operation, ongoing arthritis since childhood, ongoing venous insufficiency at least 25-30 years where her veins leak in her lower legs, ongoing high blood pressure since she was in her 20s, ongoing blood clotting 30-35 years, is in a blood thinner for a long time, and ongoing autoimmune since childhood, goes along with ankylosing spondylosis. concomitant medications she reports she has been on all her regular medications for years. Patient previously took flu vaccine in on an unknown date in. Prior vaccinations (within 4 weeks) covid 19 vaccine reported as only received the flu vaccine in Sep2020 for unknown indication. On an unknown date in Feb2021, the patient experienced body aches/it would ache in one spot then another spot, hurt more at the shot site with the first covid 19 vaccine/pain that day afterwards and on the whole left side where she had the first shot. On an unknown date, it was reported that, it was like if her left hip hurt then her right hip would start hurting. The patient underwent lab tests and procedures which included body height: she used to be 5ft 6.5in and now she is 5ft., weight: 147-148 she is not sure, both on an unknown date. The outcome of event body aches/it would ache in one spot then another spot was recovering, and outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.
Chills; nausea; intense headache; severe fatigue; muscle pain; joint pain; This is a spontaneous report from a non-contactable nurse (the patient). A 36-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not provided), via an unspecified route of administration in the right arm on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration in the right arm on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unspecified date, the patient experienced chills, nausea, intense headache, severe fatigue, muscle and joint pain that started around 10 following injection and was the worst 24 hours to about 48 hours following injection. Now 53 hours post injection, the patient was feeling close to normal. No treatment was received for the events. The clinical outcome of the events was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.    No follow up attempts are possible; information about the lot number cannot be obtained.
started itching 4 days after receiving second dose; had redness on the neck/flat red patches; swollen, flat red patches; swollen, flat red patches/breaking out with rash on all over body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (started itching 4 days after receiving second dose), ERYTHEMA (had redness on the neck/flat red patches), SWELLING (swollen, flat red patches) and RASH (swollen, flat red patches/breaking out with rash on all over body) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059E21A and 029M20A) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN, BUSPIRONE and BUPROPION for an unknown indication.   On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, the patient experienced PRURITUS (started itching 4 days after receiving second dose) and ERYTHEMA (had redness on the neck/flat red patches). 24-Aug-2021, the patient experienced SWELLING (swollen, flat red patches) and RASH (swollen, flat red patches/breaking out with rash on all over body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (started itching 4 days after receiving second dose), ERYTHEMA (had redness on the neck/flat red patches), SWELLING (swollen, flat red patches) and RASH (swollen, flat red patches/breaking out with rash on all over body) outcome was unknown.
Started feeling itchy at injection site; Red circle at injection site; Arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE PRURITUS (Started feeling itchy at injection site) and VACCINATION SITE ERYTHEMA (Red circle at injection site) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Started feeling itchy at injection site) and VACCINATION SITE ERYTHEMA (Red circle at injection site). The patient was treated with CEREVEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm hurt) had not resolved and VACCINATION SITE PRURITUS (Started feeling itchy at injection site) and VACCINATION SITE ERYTHEMA (Red circle at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
numb injection site; itchy injection site; painful injection site/pain at the right arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (numb injection site), VACCINATION SITE PRURITUS (itchy injection site) and VACCINATION SITE PAIN (painful injection site/pain at the right arm at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE HYPOAESTHESIA (numb injection site), VACCINATION SITE PRURITUS (itchy injection site) and VACCINATION SITE PAIN (painful injection site/pain at the right arm at injection site). At the time of the report, VACCINATION SITE HYPOAESTHESIA (numb injection site), VACCINATION SITE PRURITUS (itchy injection site) and VACCINATION SITE PAIN (painful injection site/pain at the right arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided. The patient had pain at the right arm at injection site. She said that it is itchy, numb and painful. She had the first dose on 2mar21.
I happened to notice my tongue swelling at 11:30 Saturday morning. I went to dinner and my friends noticed my tongue was swelling as well. I rinsed my mouth water with salt and took antihistamines. Monday and Tuesday, I emailed my doctor. I went in on Wednesday to see her. My tongue was not as swollen at that point, but I did have a sinus infection because there was fluid in my ears and there was pressure in my cheeks. I did also experience a mild cough and it is infrequent. She put me on Amoxicillin 125 mg twice daily for 5 days. I was also told to take an antihistamine with it.